is semaglutide safe during breastfeeding While Breastfeeding: Safety & Nursing Breastfeeding and Semaglutide: Safety Facts

In studies of GLP-1RA therapy in individuals with type 2 diabetes, the most frequently reported adverse events tend to involve the gastrointestinal system, with nausea, vomiting, and diarrhea occurring in up to 51%, 19%, and 20% of patients, respectively [44]

Millions of Americans have used Ozempic, Wegovy, Mounjaro or other glucagon-like peptide-1 receptor agonists (GLP-1 RA) drugs in recent years, amid aggressive promotions by the drug makers that indicated the medications were safe and effective for weight loss

With enhancement strategies, the math becomes more reasonable

Electrolytes come first

Document strength values for consistent laboratory record keeping